Validations: Continuous Manufacturing & PAT / Real-Time Release

CM Deviation Storyboards: What Inspectors Expect

CM Deviation Storyboards: What Inspectors Expect Continuous manufacturing (CM) and real-time release testing (RTRT) have transformed the pharmaceutical landscape, allowing for more efficient processes and improved product quality. However, the complexity of these systems can lead to deviations, necessitating robust validation practices and effective handling procedures. This tutorial aims to provide pharmaceutical professionals with a detailed guide on creating CM…

Continue Reading CM Deviation Storyboards: What Inspectors Expect

Exception Batches: Definitions, Labels, and Records

Exception Batches: Definitions, Labels, and Records Understanding Exception Batches in Continuous Manufacturing The concept of exception batches in the pharmaceutical industry, particularly within the framework of continuous manufacturing (CM) and process analytical technology (PAT), is critical for maintaining compliance with regulatory standards such as those outlined by the FDA, EMA, and MHRA. Exception batches are those that deviate from predefined…

Continue Reading Exception Batches: Definitions, Labels, and Records

Edge of Failure Testing in CM: How Far Is Defensible

Edge of Failure Testing in Continuous Manufacturing: How Far Is Defensible The pharmaceutical industry is undergoing a significant transformation with the integration of Continuous Manufacturing (CM) processes and Process Analytical Technology (PAT). As these advanced technologies become commonplace, it’s crucial to understand the implications and requirements surrounding failure testing in CM. This article provides a comprehensive tutorial detailing the definitions,…

Continue Reading Edge of Failure Testing in CM: How Far Is Defensible

Edge of Failure Testing in CM: How Far Is Defensible

Edge of Failure Testing in CM: How Far Is Defensible Edge of Failure Testing in Continuous Manufacturing: How Far Is Defensible Understanding Continuous Manufacturing in Pharmaceuticals Continuous Manufacturing (CM) represents a transformative approach in pharmaceutical production, advancing efficiency and product quality. Defined as a method where raw materials are continuously fed into the production process and products are continuously removed,…

Continue Reading Edge of Failure Testing in CM: How Far Is Defensible

Handling Sensor/Model Failures Mid-Run

Handling Sensor/Model Failures Mid-Run Handling Sensor/Model Failures Mid-Run in Continuous Manufacturing Continuous manufacturing (CM) has become increasingly prevalent in the pharmaceutical industry, allowing for more efficient production and enabling real-time release testing (RTRT) of products. As part of this innovative manufacturing approach, robust engineering and validation frameworks are necessitated by regulatory entities such as the FDA, EMA, and MHRA. One…

Continue Reading Handling Sensor/Model Failures Mid-Run

Handling Sensor/Model Failures Mid-Run

Handling Sensor/Model Failures Mid-Run: A Step-by-Step Tutorial In the increasingly complex landscape of pharmaceutical manufacturing, the integration of Continuous Manufacturing (CM) and Process Analytical Technology (PAT) has become integral for achieving Real-Time Release Testing (RTRT). However, the challenge of sensor or model failures mid-run remains critical. This article serves as a comprehensive guide for pharmaceutical professionals in addressing sensor and…

Continue Reading Handling Sensor/Model Failures Mid-Run

Deviation Handling in CM: Event Taxonomy and Escalation

Deviation Handling in CM: Event Taxonomy and Escalation Deviation Handling in Continuous Manufacturing: Event Taxonomy and Escalation Introduction to Deviation Handling in Continuous Manufacturing The pharmaceutical industry is increasingly adopting Continuous Manufacturing (CM) processes to enhance efficiency and streamline production. These processes offer notable advantages such as improved product quality and reduced lead time. However, with the incorporation of innovative…

Continue Reading Deviation Handling in CM: Event Taxonomy and Escalation

Diversion Rules: When to Route, Hold, or Scrap

Diversion Rules: When to Route, Hold, or Scrap Diversion Rules: When to Route, Hold, or Scrap In the evolving landscape of pharmaceutical manufacturing, particularly with the adoption of continuous manufacturing (CM) and process analytical technology (PAT), the need for robust diversion rules is paramount. This comprehensive guide will provide a step-by-step approach to understanding the diversion rules applicable in scenarios…

Continue Reading Diversion Rules: When to Route, Hold, or Scrap

Traceability in CM: Material Genealogy and Lot Claims

Traceability in Continuous Manufacturing: Material Genealogy and Lot Claims In pharmaceutical manufacturing, especially in continuous manufacturing (CM), maintaining accurate traceability of materials and product lots is crucial for ensuring compliance with regulatory standards and guaranteeing product quality. Traceability involves tracking the genealogy of materials used in production and their resultant lot claims throughout the lifecycle, enabling organizations to proactively manage…

Continue Reading Traceability in CM: Material Genealogy and Lot Claims

RTD Characterization: Practical Methods and Acceptance

RTD Characterization: Practical Methods and Acceptance RTD Characterization: Practical Methods and Acceptance The pharmaceutical industry is rapidly advancing towards a framework that embraces continuous manufacturing (CM) and real-time release testing (RTRT) methodologies, which involve process analytical technology (PAT) for the advancement in product quality and regulatory compliance. This guide serves as a comprehensive tutorial for pharmaceutical professionals to understand the…

Continue Reading RTD Characterization: Practical Methods and Acceptance